Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)
Completed
- Conditions
- Obstructive Sleep Apnea
- Registration Number
- NCT03122483
- Lead Sponsor
- Beckman Coulter, Inc.
- Brief Summary
This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 250
Inclusion Criteria
- Written Informed Consent
- Male
- 18-70 years old
- Presentation with symptoms suggestive of obstructive sleep apnea
- Diagnostic sleep study
- Blood draw
Exclusion Criteria
- Prior (within past year) or current therapy for sleep apnea
- Use of opioid pain medication, steroids or allopurinol (within past 30 days)
- Use of chronic anti-inflammatory drugs (within past 7 days)
- Active cancer under current treatment or monitoring
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of OSA in high-risk individuals 1 day Identification of OSA in high-risk individuals
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Sleep Center Orange County
🇺🇸Irvine, California, United States
Brigham and Women's Hospital
🇺🇸Boston, Massachusetts, United States
SleepMed
🇺🇸Columbia, South Carolina, United States
Sleep Center Orange County🇺🇸Irvine, California, United States